Skip to main content

Public contracts of the Alpes-de-Haute-Provence département · 2025

Vaccin hexavalent DTP coqueluche haemophilus influenzae hépatite B

€62k
framework agreement: a maximum envelope for orders over 3 years, not spending — what was paid on it is not published
Signed on 7 March 2025 · running until about March 2028 · 3 yrs
Ongoing7 Mar 2028

That is at most ~€21k a year on average: a maximum too.

Who won it

MSD FranceCommerce de gros (commerce interentreprises) de produits pharmaceutiques · registered office Puteaux (92800) · headcount 1,000 to 1,999 employees · SIREN 417890589

A contract awarded to 4 holders; above, the main holder. With it: Laboratoire Glaxosmithkline, Sanofi Winthrop Industrie, Sanofi Pasteur Europe. The amount is the whole contract’s: the DECP does not publish each holder’s share.

The competition

3 bids received

Median for this procedure in 2025: 3 bids, across 17964 comparable contracts. Open tender · awarded to 4 companies

Open data publishes the winner and the bid count — never the identity of unsuccessful bidders.

Number 119 by amount of the 142 contracts the Alpes-de-Haute-Provence département published for 2025.

Other contracts of MSD France in Alpes-de-Haute-Provence

Vaccin anti papillomavirus humain nonavalent2025 · maximum over 3 years300€kVaccin contre pneumocoque 15 valences2025 · maximum over 3 years69€kFourniture de médicaments non substituables ou sans équivalent…2024 · maximum over 4 years57€k
Contract details (procedure, price, amendments, lots)

Procedure : Appel d'offres ouvert

Framework agreement : yes: orders follow, the amount is a ceiling

Price : Unitaire

Published amendments : 4

Environmental considerations : Clause environnementale

Contracts above €40,000 excluding VAT, as declared when they are awarded (DECP): contract amounts, not payments. Smaller contracts are not published; obviously wrong amounts are set aside.